학술논문
1198P Phase Ib portion of the ACTION-1 phase Ib/3 trial of RYZ101 in gastroenteropancreatic neuroendocrine tumors (GEP-NET) progressing after 177Lu somatostatin analogue (SSA) therapy: Safety and efficacy findings
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S707-S707
Subject
Language
ISSN
0923-7534